Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utility of Combined CTC and ctDNA Assay in the Diagnosis of Primary Lung Cancer

NCT03479099 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03479099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03479099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utility of Combined CTC and ctDNA Assay in the Diagnosis of Primary Lung Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
March 12, 2018
Completion date
March 11, 2019
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cell, lung cancer (diagnosis)